Patients will receive a booster dose of Pfizer-BioNTech Coronavirus (COVID-19) vaccine at the Oakland County Health Department Vaccination Clinic in Southfield Pavilion, Southfield, Michigan, on August 24, 2021.
Emily Elconin | Getty Images
Francis Collins, director of the National Institutes of Health, called Israeli data on Covid-19 booster shots “impressive” and said it reduced infections by a factor of 10 in people who received a third dose.
Israel Start booster administration In late July, individuals over the age of 60 will be given more time for scientists to examine their ability to fight Covid and enhance the diminished effectiveness of the first series of doses.Collins’ comment Thursday was the day after the Food and Drug Administration approved Pfizer When BioNTech Covid booster for high-risk people, including those over 65.
In a discussion about Covid hosted by Bloomberg Philanthropies, Collins said, “I think the data is really impressive that boosters actually significantly reduce infections without over-tilting.” .. “This is what we are most concerned about, as it will be reduced by a factor of 10 within 12 days after the booster and the number of severe illnesses will be reduced.”
Collins added that Israeli data show that severe covids have been reduced by about one-twelfth as the country has begun to experience more groundbreaking cases. Pfizer reported on August 25 that those who received the third dose experienced a three-fold increase in antibodies.
The CDC’s Immunization Implementation Advisory Board is a committee of medical authorities that provides guidance to authorities and will vote Thursday to support the FDA’s booster decision. The panel began a series of two-day presentations on boosters on Wednesday, giving experts and the general public the opportunity to hear more data before the final vote.
NIH director Collins calls Israeli data “impressive”
Source link NIH director Collins calls Israeli data “impressive”
The post NIH director Collins calls Israeli data “impressive” appeared first on Eminetra.